Gareth Wakefield
Fondatore presso Xerion Healthcare Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ian Michael Riorden George | M | - |
Xerion Healthcare Ltd.
 Xerion Healthcare Ltd. BiotechnologyHealth Technology Xerion Healthcare Ltd. develops and commercializes nanoparticle treatment to cure head, and neck and lung cancer. It injects Nanoparticles into tumours and generates free radicals by splitting water rather than interacting with oxygen. The firm’s nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material. The company was founded by Gareth Wakefield and Helen Townley in 2015 and is headquartered in Thame, the United Kingdom. | - |
| Justin Stebbing | M | - |
Xerion Healthcare Ltd.
Xerion Healthcare Ltd. BiotechnologyHealth Technology Xerion Healthcare Ltd. develops and commercializes nanoparticle treatment to cure head, and neck and lung cancer. It injects Nanoparticles into tumours and generates free radicals by splitting water rather than interacting with oxygen. The firm’s nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material. The company was founded by Gareth Wakefield and Helen Townley in 2015 and is headquartered in Thame, the United Kingdom. | 6 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Helen Townley | M | - |
Xerion Healthcare Ltd.
Xerion Healthcare Ltd. BiotechnologyHealth Technology Xerion Healthcare Ltd. develops and commercializes nanoparticle treatment to cure head, and neck and lung cancer. It injects Nanoparticles into tumours and generates free radicals by splitting water rather than interacting with oxygen. The firm’s nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material. The company was founded by Gareth Wakefield and Helen Townley in 2015 and is headquartered in Thame, the United Kingdom. | 3 anni |
| Carolyn Porter | M | - |
Xerion Healthcare Ltd.
Xerion Healthcare Ltd. BiotechnologyHealth Technology Xerion Healthcare Ltd. develops and commercializes nanoparticle treatment to cure head, and neck and lung cancer. It injects Nanoparticles into tumours and generates free radicals by splitting water rather than interacting with oxygen. The firm’s nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material. The company was founded by Gareth Wakefield and Helen Townley in 2015 and is headquartered in Thame, the United Kingdom. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Regno Unito | 4 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Gareth Wakefield
- Contatti personali
